Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 4
290
Views
10
CrossRef citations to date
0
Altmetric
Research Articles

New pyran derivative with antioxidant and anticancer properties isolated from the probiotic Lactobacillus plantarum H24 strain

ORCID Icon, , &
Pages 909-917 | Received 17 Aug 2020, Accepted 05 Nov 2020, Published online: 23 Nov 2020
 

Abstract

This work was aimed to prepare, isolate and identify antioxidant and cytotoxic compound from the culture filtrate of a probiotic lactobacillus strain. New compound, plantarone (1), together with two known compounds, kojic acid (2) and methyl dodecanoate (3), were isolated from the ethyl acetate extract of the culture filtrate of probiotic Lactobacillus plantarum H24. Their structures were elucidated using spectroscopic methods including 2 D NMR, HRMS analyses. Isolated compounds were screened for antioxidant and cytotoxic activities against Caco-2 colon cancer cells. Compounds 1 and 2 showed lowers DPPH radical scavenging activities (p < 0.05) with IC50 values of 66.3 ± 0.34 μM and 50.2 ± 0.28 μM respectively, compared to standard butylated hydroxyanisole (BHA: IC50 = 44.2 ± 0.24 μM). Whereas only compound 1 showed a good cytotoxicity activity with inhibition value of 60.72 ± 3.55%. Accordingly, L. plantarum H24 could be used to prevent oxidative stress and its injuries, improving human health.

Graphical Abstract

Acknowledgements

We are grateful to the Third World Academy of Sciences (TWAS) and the International Center of Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan.

Disclosure statement

The authors declare no competing interests

Additional information

Funding

This research was financed by the Third World Academy of Sciences (TWAS) and International Center of Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan; through two of the authors: H.C.K.M [grant FR number: 3240299154] and A.D.K.M [grant FR number: 3240299153].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.